Search Results 1521-1530 of 19457 for Hemoglobin

1. Treatment of Moderate to Severe Refractory Crohn's Disease - Mayo Clinic

   * Hemoglobin \< 8 g/dL; * Bilirubin ≥ 2 x ULN; * Platelet count \< 100,000/?L; * Absolute neutrophil count \< 1,200/?L; * Absolute lymphocytes count \< 750 ...

2. A Study of Ubenimex in Patients with Pulmonary Arterial Hypertension - Mayo Clinic

   Hemoglobin concentration <9 g/dL at screening; Hepatic dysfunction as defined by Child-Pugh Class B or C. Participating Mayo Clinic locations. Study statuses ...

3. Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies - Mayo Clinic

   Hemoglobin ≥ 8 g/dL; Absolute neutrophil count (ANC) ≥ 0.75 x 10^3/uL without treatment with a myeloid growth factor within 3 days prior to first dose of ...

4. Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer - Mayo Clinic

   Hemoglobin > 9.0 g/dL; Serum bilirubin < 1.5 times ULN (unless Gilbert's syndrome without concurrent clinically significant liver disease; AST/ALT < 2.5 ULN ...

5. Hematology - Clinical trials

   In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

6. Pazopanib in Treating Patients with Metastatic Non-Clear Cell Kidney Cancer - Mayo Clinic

   Hemoglobin (HgB) > 9.0 g/dL; NOTE: Subjects may not have had a transfusion within 7 days of registration); Total bilirubin < 1.5 x upper limit of normal (ULN) ...

7. A Study To Evaluate The Effectiveness And Safety Of Vibegron Administered Orally For 12 Weeks To Women With Irritable Bowel Syndrome - Mayo Clinic

   Uncontrolled diabetes mellitus defined by a hemoglobin A1C level > 8%. Significant psychiatric or psychologic disorder that would preclude meaningful ...

8. Lenalidomide And Dexamethasone With Or Without Bortezomib In Treating Patients With Previously Untreated Multiple Myeloma - Mayo Clinic

   Hemoglobin (including patients who have been either transfused or treated with erythropoietin [EPO]) ≥ 9 g/dL; must be obtained within 28 days prior to ...

9. Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS) (REMODEL-1) - Mayo Clinic

   * Hemoglobin: \< 10 g/dl (\<100g/L) * Platelets: \< 100000/mm3 (\<100 x 109/L) * Absolute lymphocyte count \< 800/mm3 (\<0.8 x 109/L) * White blood cells ...

10. Neurology - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...